A Study of Minirin Melt in Patients With Nocturia
Minirin Melt Tolerance With Nocturia in the Common Practice Conditions in Czech Republic
1 other identifier
observational
588
1 country
37
Brief Summary
This is a confirmation of safety profile for Minirin Melt in clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2008
Typical duration for all trials
37 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
October 5, 2010
CompletedFirst Posted
Study publicly available on registry
October 18, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedOctober 8, 2012
October 1, 2012
2.2 years
October 5, 2010
October 5, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants with adverse events
12 months
Secondary Outcomes (2)
Number of participants with nocturnal voiding
12 months
Number of participants with adverse events
12 months
Eligibility Criteria
Primary care clinic
You may qualify if:
- patients suffering from Nocturia
You may not qualify if:
- habitual or psychogenic polydipsia
- known or suspected cardiac insufficiency and other conditions requiring treatment with diuretics
- moderate and severe renal insufficiency
- know hyponatremia
- syndrome of inappropriate ADH secretion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (37)
Private Ambulance
Blansko, Czechia
Private Ambulance
Brno, Czechia
Trauma Hospital in Brno
Brno, Czechia
Urocentrum
Brno, Czechia
Uromeda, s.r.o.
Brno, Czechia
Private Ambulance
Brno-Zábrdovice, Czechia
Private Ambulance
Bystřice pod Hostýnem, Czechia
Hospital Dečín
Děčín, Czechia
University Hospital Hradec Králové
Hradec Králové, Czechia
Hospital Jablonec nad Nisou
Jablonec nad Nisou, Czechia
Hospital Jihlava
Jihlava, Czechia
Hospital Kroměříž
Kroměříž, Czechia
Polyclinic Kuřim
Kuřim, Czechia
Private Ambulance
Moravský Krumlov, Czechia
Hospital Nové Město na Moravě
Nové Město na Moravě, Czechia
Hospital with Polyclinic Nový Jičín
Nový Jičín, Czechia
Private Ambulance
Nový Jičín, Czechia
University Hospital Olomouc
Olomouc, Czechia
City Hospital Ostrava
Ostrava, Czechia
Hospital Ostrava
Ostrava, Czechia
Private Ambulance
Ostrava, Czechia
Central Military Hospital
Prague, Czechia
Medicon, s.r.o.
Prague, Czechia
Polyclinic Barandov
Prague, Czechia
Private Ambulance
Prague, Czechia
Railway Hospital
Prague, Czechia
Thomayer´s Hospital
Prague, Czechia
University Hospital Bulovka
Prague, Czechia
Hospital Prostějov
Prostějov, Czechia
Private Ambulance
Přerov, Czechia
Hospital Šumperk
Šumperk, Czechia
Private Ambulance
Třebíč, Czechia
Hospital Uherské Hradiště
Uherské Hradiště, Czechia
Hospital Ústí nad Orlicí, Inc
Ústí nad Orlicí, Czechia
Hospital Valašské Meziříčí, Inc
Valašské Meziříčí, Czechia
T. Bata Regional Hospital, Inc.
Zlín, Czechia
Hospital Znojmo
Znojmo, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Clinical Development Support
Ferring Pharmaceuticals
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2010
First Posted
October 18, 2010
Study Start
September 1, 2008
Primary Completion
December 1, 2010
Study Completion
March 1, 2011
Last Updated
October 8, 2012
Record last verified: 2012-10